Cost-consequence analysis of using neurofarmagen in the decision making process during the treatment of patients with depression in the U.S.

dc.contributor.author	Espadaler, P.
dc.contributor.author	Carcedo, D.
dc.contributor.author	Pérez Mitre, A.
dc.contributor.author	Menchón, José M.
dc.contributor.author	Saiz Ruiz, J.
dc.contributor.author	Bobes, Julio
dc.contributor.author	Vieta Pascual, Eduard
dc.contributor.author	Álvarez, Enric
dc.contributor.author	Pérez, V
dc.date.accessioned	2018-02-28T10:40:57Z
dc.date.available	2018-02-28T10:40:57Z
dc.date.issued	2017
dc.identifier.issn	1098-3015
dc.identifier.issn	1524-4733
dc.identifier.uri	http://hdl.handle.net/10651/46093
dc.language.iso	eng
dc.relation.ispartof	Value In Health, 20
dc.rights	©,
dc.source	WOS:000413599902429
dc.title	Cost-consequence analysis of using neurofarmagen in the decision making process during the treatment of patients with depression in the U.S.
dc.type	conference output	spa
dc.identifier.doi	10.1016/j.jval.2017.08.1891
dc.relation.publisherversion	https://doi.org/10.1016/j.jval.2017.08.1891

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.